SHMARQL

cabergoline

<http://www.wikidata.org/entity/Q423308>

chemical compound
rdfs:label
"cabergoline"@en
skos:altLabel
"(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide"@en
"(8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide"@en
"(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide"@en
"(8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide"@en
"1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea"@en
"1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea"@en
"1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea"@en
"1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea"@en
"1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea"@en
"1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea"@en
"Cabaser®"@en
"Cabergolina"@en
"Cabergoline"@en
"Cabergolinum"@en
"Caberlin®"@en
schema:description
"chemical compound"@en
schema:dateModified "2026-08-13T18:46:39+00:00"^^xsd:dateTime
schema:version 2530977364
wikibase:identifiers 39
wikibase:sitelinks 25
wikibase:statements 84
p:P10245 wd:statement/Q423308-62d6bf6c-483b-0f0b-8b91-26fcbcd26feb
p:P10283 wd:statement/Q423308-6967062D-10B0-4EF2-8455-1CC6E6095A6E
p:P11089 wd:statement/Q423308-820E66F2-18DA-48B6-9D9A-F7E785D450E6
p:P11143 wd:statement/Q423308-60019B8F-CD41-4910-8239-BDDBB07DDD4C
p:P11198 wd:statement/Q423308-B2000659-F858-4CCA-9249-9D94055814F5
p:P11199 wd:statement/Q423308-EDE1A6D5-9A4E-4680-9CBD-0884442FDFFB
p:P117 wd:statement/Q423308-28D86E6A-98AB-4D5B-ABB8-C81CE5324A2E
wd:statement/Q423308-70a09756-438d-eb5e-3bb2-8fe2cd1bcaf8
p:P129 wd:statement/Q423308-19E97E78-FC88-4884-9622-D9039D512560
wd:statement/Q423308-2C3F0F63-2B2B-47F9-B121-83CE9FEB5760
wd:statement/Q423308-4F799A46-BCD9-412D-B348-A4B7F1879589
wd:statement/Q423308-534B5C9D-FB7F-4246-93F4-D5C09A3594B6
wd:statement/Q423308-551696A7-190A-4D64-AE1B-EB5AE80B9F8F
wd:statement/Q423308-902E5152-2C54-4236-A1B6-3C1C74E6B7B5
wd:statement/Q423308-92FDD564-27A4-4FCC-AF93-3B949693FA0D
wd:statement/Q423308-B58A2ED3-01F4-4DD1-A757-4B95CEA8B738
wd:statement/Q423308-BC8C0AB9-DFB3-483C-BB2D-96D2BC83BE11
wd:statement/Q423308-C9391F2C-8251-48C8-BC81-A650722CC1B7
wd:statement/Q423308-D0B16F36-E19A-47A9-AD08-60F894D22A50
wd:statement/Q423308-D7E7B6D7-A322-422E-BA73-9C06AF7260B1
wd:statement/Q423308-E2E96104-E664-47F6-8243-0E36C1BE215A
wd:statement/Q423308-E9E67B26-E3A8-4088-8AC8-9901E3C11F83
wd:statement/Q423308-F3162D7A-31A0-4A43-B793-9C70F24EA707
p:P1579 wd:statement/Q423308-70765213-AAD6-4CED-8BC4-6A6813A9C38E
p:P2017 wd:statement/Q423308-DA59ED08-1AE7-4CE0-9956-A71D0A0FA6F3
p:P2057 wd:statement/Q423308-2F45A19A-0ED4-4EDF-B886-577DA262BFF4
p:P2067 wd:statement/Q423308-11DF27FB-A002-44F3-B0F9-745353312697
p:P2115 wd:statement/Q423308-E3176FEC-2F28-4C01-B997-6B8A6E98D0BE
p:P2175 wd:statement/Q423308-16dcfabd-4aba-b8ca-018a-7f3432460133
wd:statement/Q423308-3A9079AC-E5F7-41E1-AA14-E44C93BD82E5
wd:statement/Q423308-6CBA574C-75CF-4F63-8B24-BCC6B83F3B5C
wd:statement/Q423308-9FD9AB64-A1C1-4CE8-B674-816F3C72170B
wd:statement/Q423308-D54AECB0-DAB2-4439-8F37-0878A72D173F
p:P2275 wd:statement/Q423308-8B3D6CAF-992E-4531-9A5E-CB9A375AAB6E
p:P231 wd:statement/Q423308-E17EE84F-A3EC-47BA-940C-6F559E380FFB
p:P232 wd:statement/Q423308-4e6cd739-4cd0-714a-8c11-2c2a318dd10c
p:P233 wd:statement/Q423308-361B5283-5E58-49E9-9EBA-723F5D4B453E
p:P234 wd:statement/Q423308-7A5A7073-36D8-4FD5-81B3-99770397A0E7
p:P235 wd:statement/Q423308-5CDFA997-86BA-4A98-A24C-BA99EC3ED32C
p:P2566 wd:statement/Q423308-4F3B05D8-5E03-489F-B60F-7086046851AC
p:P267 wd:statement/Q423308-91583486-314C-4112-9AB3-B94ABF6391F0
wd:statement/Q423308-D14F41E2-B841-46DC-8DB5-95221DCB6265
p:P274 wd:statement/Q423308-352FEA7C-6C3B-4E73-8E05-8DC605E85ED8
p:P279 wd:statement/Q423308-2FA5EB2D-89B0-4907-8C55-C429D421E6F8
p:P2868 wd:statement/Q423308-8D622FF7-DC92-43A0-B882-1F663B3F1D5E
wd:statement/Q423308-8EB914C4-8971-4D74-BE63-7AA0710DB2C9
wd:statement/Q423308-985D608A-3433-4829-9D68-8D0974767C0E
p:P2877 wd:statement/Q423308-470BB196-EF6A-426A-BC7A-143F25A6A0A0
p:P2892 wd:statement/Q423308-05B6E67C-E800-4AB9-9881-141C4704EECF
p:P31 wd:statement/Q423308-445D759C-131C-4F90-AC5E-BF8551D4D902
p:P3117 wd:statement/Q423308-F5363222-4F43-4B13-87B0-8D6175741232
p:P3345 wd:statement/Q423308-E706D593-DAA4-46A7-8DAB-2FECBCE9B990
p:P3417 wd:statement/Q423308-7BE957D3-C83B-4DC6-88E7-E6E1C2867BD5
p:P3489 wd:statement/Q423308-19626145-1A5C-4F19-B4B9-7FD1A8A350E8
p:P366 wd:statement/Q423308-837CA942-C92A-4754-8BAD-5626C92A30D8
p:P373 wd:statement/Q423308-f97d598b-de09-46c7-8457-86b6decbf96b
p:P4250 wd:statement/Q423308-33159A40-8CF9-482D-B4F4-0412E6BF6A57
wd:statement/Q423308-34629FE3-21DB-4512-9F36-08F636632465
p:P486 wd:statement/Q423308-193EFC87-D4B1-43DF-AAF4-F82894909700
p:P5076 wd:statement/Q423308-EAAD8A7B-F9E6-4E4A-8912-28C7ED20DF31
p:P592 wd:statement/Q423308-800B3109-1EB9-43C0-835E-99958E51BEC1
p:P595 wd:statement/Q423308-43E7F86B-6B43-4936-AD18-EA56B28864EB
p:P6366 wd:statement/Q423308-058B6065-23EB-456E-8CB1-4708CAC5685A
p:P646 wd:statement/Q423308-FB53C5F4-F7D2-46E7-9D73-B84A1A068884
p:P652 wd:statement/Q423308-CAAF0DB2-C076-401E-9A48-22518FA1E23B
p:P661 wd:statement/Q423308-926F6C9C-2A44-48FC-B94D-C736238180ED
p:P662 wd:statement/Q423308-49140010-6421-439B-B8DF-A320746149C4
p:P665 wd:statement/Q423308-4FF27BCD-6B64-4EAF-BD7F-64288631B1F0
wd:statement/Q423308-C1188E5F-E95F-49A8-8A5B-1D838D99DDEC
p:P672 wd:statement/Q423308-64ae05f5-4ebf-1b78-6211-f4eb2073ea23
wd:statement/Q423308-740ebcb0-4093-2bbd-1b7e-db6ec9be4b79
p:P683 wd:statement/Q423308-75F4E2BD-704D-466C-AE05-E4E374C77A7B
p:P715 wd:statement/Q423308-5969ECCE-355C-47C0-90C2-CC1CDAE1FC8A
p:P769 wd:statement/Q423308-1754F4B8-124C-4CC3-A74D-E58FED4C03D3
wd:statement/Q423308-2E7BF81A-A27F-451F-B894-15F0018AC8DE
wd:statement/Q423308-31643EB9-9EB3-4854-9062-6BCCDB9983E6
wd:statement/Q423308-41A434FE-0C2F-4657-845E-A53F6B653903
wd:statement/Q423308-92DC5EF9-9F3E-420E-9896-29923A4D2E67
wd:statement/Q423308-942587DC-C589-4534-995A-B7333C46C2CB
wd:statement/Q423308-AFA655B1-C40E-43A0-8736-6C184D656CEE
wd:statement/Q423308-F6441799-5E56-46A3-8E2D-388D3FC98837
p:P8494 wd:statement/Q423308-F09342AE-07D2-4EBD-A47E-90A5B8C4756A
p:P9272 wd:statement/Q423308-18337D08-1B07-4E08-B9E7-55A0358AE9E1
p:P9635 wd:statement/Q423308-5B20C629-9C73-4842-A712-6D7DB214F54A
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148483>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D000077465>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201087>
p:direct-normalized/P6366 <https://makg.org/entity/2779832395>
p:direct-normalized/P661 <http://rdf.chemspider.com/49452>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54746>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C08187>
<http://www.kegg.jp/entry/D00987>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/D03.132.327.287.131>
<http://id.nlm.nih.gov/mesh/D03.633.400.439.197>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_3286>
wdt:P10245 "a612020"
wdt:P10283 "C2779832395"
wdt:P11089 "610539"
wdt:P11143 "Cabergoline"
wdt:P11198 "460"
wdt:P11199 "PD010146"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Cabergolin.svg>
<http://commons.wikimedia.org/wiki/Special:FilePath/Cabergoline.svg>
wdt:P129 5-hydroxytryptamine receptor 2A
Dopamine receptor D2
5-hydroxytryptamine receptor 2C
Dopamine receptor D1
Dopamine receptor D3
5-hydroxytryptamine receptor 1A
5-hydroxytryptamine receptor 1D
Dopamine receptor D5
Adrenoceptor alpha 2B
5-hydroxytryptamine receptor 1B
Dopamine receptor D4
5-hydroxytryptamine receptor 2B
Adrenoceptor alpha 1A
Adrenoceptor alpha 2C
Adrenoceptor alpha 2A
wdt:P1579 "6020775"
wdt:P2017 "CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C"
wdt:P2057 "HMDB0014393"
wdt:P2067 451.294725^^xsd:decimal
wdt:P2115 "N0000148483"
wdt:P2175 Parkinson's disease
hyperprolactinemia
prolactin producing pituitary tumor
benign neoplasm of pituitary gland
prolactinoma
wdt:P2275 "cabergoline"@en
wdt:P231 "81409-90-7"
wdt:P232 "627-031-8"
wdt:P233 "CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C"
wdt:P234 "InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1"
wdt:P235 "KORNTPPJEAJQIU-KJXAQDMKSA-N"
wdt:P2566 "100.155.380"
wdt:P267 "G02CB03"
"N04BC06"
wdt:P274 "C₂₆H₃₇N₅O₂"
wdt:P279 ergoline alkaloid
wdt:P2868 antineoplastic
antiparkinson
dopamine agonist
wdt:P2877 "42292"
wdt:P2892 "C0107994"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID6022719"
wdt:P3345 "47579"
wdt:P3417 "Cabergoline"
wdt:P3489 US pregnancy category B
wdt:P366 medication
wdt:P373 "Cabergoline"
wdt:P4250 0.5^^xsd:decimal
3.0^^xsd:decimal
wdt:P486 "D000077465"
wdt:P5076 "RD-03-00015"
wdt:P592 "CHEMBL1201087"
wdt:P595 "37"
wdt:P6366 "2779832395"
wdt:P646 "/m/051b_1"
wdt:P652 "LL60K9J05T"
wdt:P661 "49452"
wdt:P662 "54746"
wdt:P665 "C08187"
"D00987"
wdt:P672 "D03.132.327.287.131"
"D03.633.400.439.197"
wdt:P683 "3286"
wdt:P715 "DB00248"
wdt:P769 droperidol
zuclopenthixol
haloperidol
chlorpromazine
levomepromazine
(Z)-flupentixol
(RS)-sulpiride
fluphenazine
wdt:P8494 "DTXCID502719"
wdt:P9272 "57653"
wdt:P9635 "593"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata